Gastric amyloidosis

Clinicopathological correlations in 79 cases from a single institution

Samar M. Said, Karen L. Grogg, Thomas Christopher Smyrk

Research output: Contribution to journalArticle

Abstract

Summary Gastrointestinal involvement by amyloidosis is common, but large clinicopathological studies specifically addressing gastric amyloidosis are lacking. Seventy-nine patients with biopsy-proven, gastric amyloidosis were identified by a retrospective review of our pathology archives, from 2007 to 2013. Amyloid typing was performed by laser microdissection/mass spectrometry (in 44 patients), immunohistochemistry, immunofluorescence, and/or genetic testing. The median age at diagnosis was 62 years, with 61% being males. The amyloid was derived from immunoglobulin light chain (67%), transthyretin (ATTR) (18%), serum amyloid A (9%), and apolipoprotein A1 (3%). When other gastrointestinal sites were biopsied, amyloid was demonstrated in the small bowel (89%), colon (81%), and esophagus (33%). The most common gastrointestinal manifestations were weight loss (37%), abdominal pain/dyspepsia (23%), and nausea/vomiting (23%). Endoscopic findings included normal (35%), erythema (33%), erosions (18%), and nodularity (15%) and were not related to amyloid type. No case showed gastric lymphoma. The most common location of amyloid was the muscularis mucosae regardless of the type of amyloid. Lamina propria involvement was less frequent in ATTR than other types. In 22% of patients, the first diagnosis of amyloid was based on the gastric biopsy. Patients' survival at 3 years was 60% and was not different by type of amyloid. Our study shows that light-chain amyloidosis is the most common form of gastric amyloidosis, followed by ATTR. Type of amyloid cannot be predicted based on clinical or endoscopic findings, and therefore, biopsy with amyloid typing, preferably by laser microdissection/mass spectrometry, is critical to establish the correct diagnosis, prognosis, and appropriate treatment.

Original languageEnglish (US)
Pages (from-to)491-498
Number of pages8
JournalHuman Pathology
Volume46
Issue number4
DOIs
StatePublished - Apr 1 2015

Fingerprint

Amyloidosis
Amyloid
Stomach
Microdissection
Biopsy
Mass Spectrometry
Mucous Membrane
Lasers
Immunoglobulin Light Chains
Serum Amyloid A Protein
Prealbumin
Dyspepsia
Apolipoprotein A-I
Genetic Testing
Erythema
Nausea
Abdominal Pain
Esophagus
Vomiting
Fluorescent Antibody Technique

Keywords

  • AL amyloidosis
  • Amyloid typing
  • Gastric amyloidosis
  • Gastrointestinal amyloidosis
  • Mass spectrometry

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Gastric amyloidosis : Clinicopathological correlations in 79 cases from a single institution. / Said, Samar M.; Grogg, Karen L.; Smyrk, Thomas Christopher.

In: Human Pathology, Vol. 46, No. 4, 01.04.2015, p. 491-498.

Research output: Contribution to journalArticle

Said, Samar M. ; Grogg, Karen L. ; Smyrk, Thomas Christopher. / Gastric amyloidosis : Clinicopathological correlations in 79 cases from a single institution. In: Human Pathology. 2015 ; Vol. 46, No. 4. pp. 491-498.
@article{22f0a121c8b44efa8c5dd297fdd3a33e,
title = "Gastric amyloidosis: Clinicopathological correlations in 79 cases from a single institution",
abstract = "Summary Gastrointestinal involvement by amyloidosis is common, but large clinicopathological studies specifically addressing gastric amyloidosis are lacking. Seventy-nine patients with biopsy-proven, gastric amyloidosis were identified by a retrospective review of our pathology archives, from 2007 to 2013. Amyloid typing was performed by laser microdissection/mass spectrometry (in 44 patients), immunohistochemistry, immunofluorescence, and/or genetic testing. The median age at diagnosis was 62 years, with 61{\%} being males. The amyloid was derived from immunoglobulin light chain (67{\%}), transthyretin (ATTR) (18{\%}), serum amyloid A (9{\%}), and apolipoprotein A1 (3{\%}). When other gastrointestinal sites were biopsied, amyloid was demonstrated in the small bowel (89{\%}), colon (81{\%}), and esophagus (33{\%}). The most common gastrointestinal manifestations were weight loss (37{\%}), abdominal pain/dyspepsia (23{\%}), and nausea/vomiting (23{\%}). Endoscopic findings included normal (35{\%}), erythema (33{\%}), erosions (18{\%}), and nodularity (15{\%}) and were not related to amyloid type. No case showed gastric lymphoma. The most common location of amyloid was the muscularis mucosae regardless of the type of amyloid. Lamina propria involvement was less frequent in ATTR than other types. In 22{\%} of patients, the first diagnosis of amyloid was based on the gastric biopsy. Patients' survival at 3 years was 60{\%} and was not different by type of amyloid. Our study shows that light-chain amyloidosis is the most common form of gastric amyloidosis, followed by ATTR. Type of amyloid cannot be predicted based on clinical or endoscopic findings, and therefore, biopsy with amyloid typing, preferably by laser microdissection/mass spectrometry, is critical to establish the correct diagnosis, prognosis, and appropriate treatment.",
keywords = "AL amyloidosis, Amyloid typing, Gastric amyloidosis, Gastrointestinal amyloidosis, Mass spectrometry",
author = "Said, {Samar M.} and Grogg, {Karen L.} and Smyrk, {Thomas Christopher}",
year = "2015",
month = "4",
day = "1",
doi = "10.1016/j.humpath.2014.12.009",
language = "English (US)",
volume = "46",
pages = "491--498",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Gastric amyloidosis

T2 - Clinicopathological correlations in 79 cases from a single institution

AU - Said, Samar M.

AU - Grogg, Karen L.

AU - Smyrk, Thomas Christopher

PY - 2015/4/1

Y1 - 2015/4/1

N2 - Summary Gastrointestinal involvement by amyloidosis is common, but large clinicopathological studies specifically addressing gastric amyloidosis are lacking. Seventy-nine patients with biopsy-proven, gastric amyloidosis were identified by a retrospective review of our pathology archives, from 2007 to 2013. Amyloid typing was performed by laser microdissection/mass spectrometry (in 44 patients), immunohistochemistry, immunofluorescence, and/or genetic testing. The median age at diagnosis was 62 years, with 61% being males. The amyloid was derived from immunoglobulin light chain (67%), transthyretin (ATTR) (18%), serum amyloid A (9%), and apolipoprotein A1 (3%). When other gastrointestinal sites were biopsied, amyloid was demonstrated in the small bowel (89%), colon (81%), and esophagus (33%). The most common gastrointestinal manifestations were weight loss (37%), abdominal pain/dyspepsia (23%), and nausea/vomiting (23%). Endoscopic findings included normal (35%), erythema (33%), erosions (18%), and nodularity (15%) and were not related to amyloid type. No case showed gastric lymphoma. The most common location of amyloid was the muscularis mucosae regardless of the type of amyloid. Lamina propria involvement was less frequent in ATTR than other types. In 22% of patients, the first diagnosis of amyloid was based on the gastric biopsy. Patients' survival at 3 years was 60% and was not different by type of amyloid. Our study shows that light-chain amyloidosis is the most common form of gastric amyloidosis, followed by ATTR. Type of amyloid cannot be predicted based on clinical or endoscopic findings, and therefore, biopsy with amyloid typing, preferably by laser microdissection/mass spectrometry, is critical to establish the correct diagnosis, prognosis, and appropriate treatment.

AB - Summary Gastrointestinal involvement by amyloidosis is common, but large clinicopathological studies specifically addressing gastric amyloidosis are lacking. Seventy-nine patients with biopsy-proven, gastric amyloidosis were identified by a retrospective review of our pathology archives, from 2007 to 2013. Amyloid typing was performed by laser microdissection/mass spectrometry (in 44 patients), immunohistochemistry, immunofluorescence, and/or genetic testing. The median age at diagnosis was 62 years, with 61% being males. The amyloid was derived from immunoglobulin light chain (67%), transthyretin (ATTR) (18%), serum amyloid A (9%), and apolipoprotein A1 (3%). When other gastrointestinal sites were biopsied, amyloid was demonstrated in the small bowel (89%), colon (81%), and esophagus (33%). The most common gastrointestinal manifestations were weight loss (37%), abdominal pain/dyspepsia (23%), and nausea/vomiting (23%). Endoscopic findings included normal (35%), erythema (33%), erosions (18%), and nodularity (15%) and were not related to amyloid type. No case showed gastric lymphoma. The most common location of amyloid was the muscularis mucosae regardless of the type of amyloid. Lamina propria involvement was less frequent in ATTR than other types. In 22% of patients, the first diagnosis of amyloid was based on the gastric biopsy. Patients' survival at 3 years was 60% and was not different by type of amyloid. Our study shows that light-chain amyloidosis is the most common form of gastric amyloidosis, followed by ATTR. Type of amyloid cannot be predicted based on clinical or endoscopic findings, and therefore, biopsy with amyloid typing, preferably by laser microdissection/mass spectrometry, is critical to establish the correct diagnosis, prognosis, and appropriate treatment.

KW - AL amyloidosis

KW - Amyloid typing

KW - Gastric amyloidosis

KW - Gastrointestinal amyloidosis

KW - Mass spectrometry

UR - http://www.scopus.com/inward/record.url?scp=85047698614&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047698614&partnerID=8YFLogxK

U2 - 10.1016/j.humpath.2014.12.009

DO - 10.1016/j.humpath.2014.12.009

M3 - Article

VL - 46

SP - 491

EP - 498

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

IS - 4

ER -